Identified by CAS number 137525-51-0, BPC-157 meets documentation and traceability requirements expected by European academic, pharmaceutical, and private research institutions
This multi-modal activity profile distinguishes Cerebrolysin from single-target neuroprotective compounds
providing PEA 800 mg, Scutellaria baicalensis 800 mg, Boswellia serrata extract 500 mg and Harpagophytum procumbens root extract 400 mg per day) over 3 months and reported a significant reduction in pain intensity
Add celery, lime leaves, lemongrass, green onions, galangal, pepper, and salt
Although iron chelators have demonstrated neuroprotection in animal models, their use in human trials has been constrained by insufficient CNS biodistribution